Lattuada, E., M. Lanzafame, C. Grosso, and F. Soldani, et al. 2009. “Optimal Fosamprenavir Regimen to Prevent Lipid Abnormalities”. Acta Biomedica Atenei Parmensis 80 (3): 200-202. https://mattioli1885journals.com/index.php/actabiomedica/article/view/1171.